It is not intended for human or veterinary use, clinical administration, diagnostic procedures, or any form of therapeutic use
Mounjaro contains tirzepatide, which is commonly discussed as a dual GLP-1 and GIP receptor agonist
Diabetes 15 , 818822 (2024)
The dual-agonist format uses the same cagrilintide + semaglutide pairing that delivered a 14.2% mean body-weight reduction at 68 weeks in Novo Nordisk's April 2024 Phase 3 type 2 diabetes readout, versus 10.2% for semaglutide alone [3]
The doses used in compounded semaglutide formulations vary between providers but are generally within the range used for B12 maintenance or mild deficiency correction
Most PlexusDx patients report stable hair health 4-6 months after shedding peaks, especially with continued attention to nutrition